Do Insider Sales At Progressive (PGR) Undercut Its Story Of Relentless Underwriting Discipline?

بروغريسيف كورب

Progressive Corporation

PGR

0.00

  • Over the past year, several Progressive insiders reduced their holdings, including VP & CFO John Sauerland, who sold about US$2.60 million of shares at prices above current levels, while management continued to emphasize underwriting profitability and disciplined capacity allocation across Personal, Commercial, and Property lines.
  • This combination of insider selling and a continued focus on refined segmentation, product model enhancements, and margin protection has sharpened investor attention on how Progressive balances growth with risk control.
  • With Progressive highlighting strong underwriting discipline as a core strength, we’ll now examine how this focus shapes the company’s broader investment narrative.

This technology could replace computers: discover 29 stocks that are working to make quantum computing a reality.

Progressive Investment Narrative Recap

To own Progressive, you need to believe its underwriting discipline and data advantages can still create value even as auto and property risks evolve. The recent insider selling, including the VP & CFO’s US$2.60 million sale above today’s price, has not visibly altered the near term focus on underwriting profitability as the key catalyst or softened the central risk around rising claim costs and competitive pressure.

The most relevant recent development here is Progressive’s Q1 2026 update, where management again framed performance around underwriting results and capacity allocation across Personal, Commercial, and Property lines. In the context of insider selling, that consistent message keeps attention on how well pricing, segmentation, and product model changes can protect margins if claim severity or competitive intensity pick up.

Yet while underwriting discipline is a strength, investors should also be aware of how persistent inflation in auto repair and medical costs could...

Progressive’s narrative projects $101.7 billion revenue and $9.5 billion earnings by 2029. This requires 4.4% yearly revenue growth and a $2.1 billion earnings decrease from $11.6 billion.

Uncover how Progressive's forecasts yield a $230.71 fair value, a 13% upside to its current price.

Exploring Other Perspectives

PGR 1-Year Stock Price Chart
PGR 1-Year Stock Price Chart

Some of the lowest estimate analysts were already cautious, assuming earnings fall to about US$8.7 billion by 2028 even as revenue rises to around US$104.1 billion. Compared with optimism around Progressive’s analytics and pricing, this is a much more pessimistic view of margin pressure. After the recent insider selling and leadership transition news, you may find your own view shifts somewhere between these bookends.

Explore 12 other fair value estimates on Progressive - why the stock might be worth just $230.71!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Progressive research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Progressive research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Progressive's overall financial health at a glance.

Curious About Other Options?

The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:

  • AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
  • Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
  • Uncover the next big thing with 25 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.